The Fort Worth Press - Warmer noses are better at fighting colds: study

USD -
AED 3.672502
AFN 62.000555
ALL 81.606681
AMD 368.629997
ANG 1.79046
AOA 918.000091
ARS 1391.994102
AUD 1.378873
AWG 1.80125
AZN 1.69346
BAM 1.669747
BBD 2.014096
BDT 122.750925
BGN 1.66992
BHD 0.37725
BIF 2975.5
BMD 1
BND 1.272576
BOB 6.910389
BRL 5.011403
BSD 1.000004
BTN 95.654067
BWP 13.471587
BYN 2.786502
BYR 19600
BZD 2.011227
CAD 1.37045
CDF 2241.000273
CHF 0.78187
CLF 0.02254
CLP 887.119996
CNY 6.79095
CNH 6.78489
COP 3792.77
CRC 455.222638
CUC 1
CUP 26.5
CVE 94.450451
CZK 20.765297
DJF 177.719776
DKK 6.380285
DOP 59.250129
DZD 132.50079
EGP 52.869685
ERN 15
ETB 157.374979
EUR 0.853801
FJD 2.18585
FKP 0.739209
GBP 0.739695
GEL 2.680069
GGP 0.739209
GHS 11.299033
GIP 0.739209
GMD 73.000244
GNF 8777.500643
GTQ 7.629032
GYD 209.214666
HKD 7.83285
HNL 26.609988
HRK 6.435099
HTG 130.601268
HUF 305.721498
IDR 17522.65
ILS 2.907703
IMP 0.739209
INR 95.717902
IQD 1310
IRR 1313000.000197
ISK 122.610046
JEP 0.739209
JMD 158.150852
JOD 0.708971
JPY 157.908501
KES 129.29594
KGS 87.449871
KHR 4010.999789
KMF 421.000019
KPW 900.016801
KRW 1490.696037
KWD 0.30819
KYD 0.833362
KZT 469.348814
LAK 21949.999503
LBP 89750.815528
LKR 324.546762
LRD 183.149855
LSL 16.409467
LTL 2.95274
LVL 0.604891
LYD 6.32502
MAD 9.17375
MDL 17.150468
MGA 4175.00024
MKD 52.636972
MMK 2099.28391
MNT 3579.674299
MOP 8.066645
MRU 39.99976
MUR 46.902386
MVR 15.41023
MWK 1741.480379
MXN 17.188897
MYR 3.930346
MZN 63.898647
NAD 16.409815
NGN 1369.890043
NIO 36.705005
NOK 9.192801
NPR 153.052216
NZD 1.68357
OMR 0.384499
PAB 1.000021
PEN 3.428501
PGK 4.35995
PHP 61.61401
PKR 278.597017
PLN 3.620465
PYG 6115.348988
QAR 3.643498
RON 4.444696
RSD 100.225995
RUB 73.223414
RWF 1460
SAR 3.758072
SBD 8.032258
SCR 13.749909
SDG 600.503963
SEK 9.318535
SGD 1.272955
SHP 0.746601
SLE 24.597814
SLL 20969.502105
SOS 571.497463
SRD 37.19397
STD 20697.981008
STN 21.25
SVC 8.749995
SYP 110.578962
SZL 16.485024
THB 32.329501
TJS 9.365014
TMT 3.51
TND 2.880505
TOP 2.40776
TRY 45.434978
TTD 6.784798
TWD 31.510503
TZS 2601.398801
UAH 43.974218
UGX 3749.695849
UYU 39.725261
UZS 12078.00005
VES 508.06467
VND 26346
VUV 117.978874
WST 2.702738
XAF 560.031931
XAG 0.011476
XAU 0.000213
XCD 2.70255
XCG 1.802233
XDR 0.694969
XOF 558.499644
XPF 102.303264
YER 238.625028
ZAR 16.40639
ZMK 9001.200062
ZMW 18.875077
ZWL 321.999592
  • CMSD

    -0.0400

    23.56

    -0.17%

  • CMSC

    -0.0600

    23.05

    -0.26%

  • NGG

    -0.2600

    86.98

    -0.3%

  • RELX

    -1.1500

    31.62

    -3.64%

  • BCC

    -0.9500

    66.98

    -1.42%

  • RBGPF

    -0.2100

    60.79

    -0.35%

  • GSK

    0.0900

    50.99

    +0.18%

  • BCE

    -0.0800

    24.39

    -0.33%

  • RIO

    2.5400

    112.04

    +2.27%

  • JRI

    -0.0100

    13.13

    -0.08%

  • RYCEF

    -0.1700

    16.03

    -1.06%

  • VOD

    0.4150

    15.51

    +2.68%

  • AZN

    3.1800

    187.72

    +1.69%

  • BTI

    1.7100

    65.35

    +2.62%

  • BP

    -0.2600

    44.14

    -0.59%

Warmer noses are better at fighting colds: study
Warmer noses are better at fighting colds: study / Photo: © AFP

Warmer noses are better at fighting colds: study

Chilly weather and common respiratory infections often go hand in hand.

Text size:

Reasons for this include people gather inside more in winter, and viruses survive better in low-humidity indoor air. But there has been less certainty about whether lower temperatures actually impair human immunity and, if so, how.

Now, a new study published Tuesday in The Journal of Allergy and Clinical Immunology details a previously unknown way that the immune system attacks viral intruders inside the nose -- and finds it works better when it's warm.

These discoveries could pave the way for an eventual treatment against the common cold and other viruses, Mansoor Amiji, a pharmaceutical sciences professor at Northeastern University, who co-led the research, told AFP.

The starting point was previous research by Amiji and colleagues in 2018, which found that nasal cells released "extracellular vesicles" (EVs) —- a spray of tiny sacs that swarmed and destroyed bacteria upon inhalation.

"The best analogy that we have is a hornet's nest," said Amiji. Like hornets defending a nest from attack, EVs swarm, bind to, and kill invaders.

For the new research, the team set out to answer two questions: are EVs also secreted in the nose in the presence of viral infections? And, if they are, is the strength of their response linked to temperature?

To answer the first question, they used a test substance which mimics a viral infection to stimulate nasal mucosa -- a thin tissue that lines the nose -- that was taken from volunteers who had surgery to remove polyps.

They found it did in fact produce EVs that target viruses.

In order to tackle the second question, they divided the nasal cell samples into two groups and cultured them in a lab, subjecting one set of samples to 37 degrees Celsius, and the other to 32C.

These temperatures were chosen based on a separate test that found the temperature inside the nose falls by about 5C when outside air drops from 23C to 4C.

Under regular body heat conditions, the EVs were successfully able to fight off viruses, by presenting them with "decoy" targets that they latch on to instead of the receptors they would otherwise target on cells.

But under the reduced temperatures, fewer EVs were produced, and those that were made packed less punch against the invaders tested: two rhinoviruses and a non-Covid coronavirus, which are typically found in winter cold season.

"There's never been a convincing reason why you have this very clear increase in viral infectivity in the cold months," said co-author Benjamin Bleier, a surgeon at Harvard Medical School and Massachusetts Eye and Ear, in a statement.

"This is the first quantitative and biologically plausible explanation that has been developed."

One of the most exciting aspects of the work is the potential to rev up the body's natural production of virus-targeting EVs in order to fight or even fend off the cold -- or even the flu and Covid, said Amiji.

"That's an area of great interest for us and we certainly continue to pursue that," he said.

L.Davila--TFWP